Pentoxifylline differentially regulates migration and respiratory burst activity of the neutrophil

Annals of the New York Academy of Sciences

Volumn 832, Issue , 1997, Pages 330-340

  Dunzendorfer, Stefan ^a   Schratzberger, Peter ^a   Reinisch, Norbert ^a   Kähler, Christian M ^a   Wiedermann, Christian J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; METHYLXANTHINE DERIVATIVE; OXYGEN RADICAL; PENTOXIFYLLINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SUPEROXIDE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DEGRANULATION; DRUG EFFECT; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MACROPHAGE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; RESPIRATORY BURST; SEPTIC SHOCK;

EID: 0031574243     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb46261.x     Document Type: Conference Paper

References (27)

1. BEUTLER, B. & A. CERAMI. 1986. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320: 584-588.
2. THUS, L. G. & C. E. HACK. 1995. Time course of cytokine levels in sepsis. Intens. Care Med. 21: S258-S263.
3. ABRAHAM, E., R. WUNDERINK, H. SILVERMANN, T. M. PERL, S. NASRAWAY, H. LEVY, R. BONE, R. P. WENZEL, R. BALK & R. ALLRED. 1995. Efficacy and safety of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis syndrome. J. Am. Med. Assoc. 273: 931-934.
4. KAWAKAMI, M., H. TSUTSUMI, T. KUMAKAWA, H. ABE, M. HIRAI, S. KUROSAWA, M. MORI & M. FUKUSHIMA. 1990. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76: 1962.
5. LANG, C. H., G. J. BAGBY, C. DOBRESCU, S. NELSON & J. J. SPITZER. 1992. Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake. J. Infect. Dis. 166: 336.
6. ROILIDES, E., T. J. WALSH, P. A. PIZZO & M. RUBIN. 1991. Granulocyte colony-stimulating factor enhances the phagocytotic and bactericidal activity of normal and defective human neutrophils. J. Infect. Dis. 163: 579.
7. YUO, A., S. KITAGAWA, A. OHSAKA, M. OHTA, K. MIYAZONO, T. OKABE, A. URABE, M. SAITO & F. TAKAKU. 1989. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74: 2144-2149.
8. HARTUNG, T., W. D. DOCKE, F. GANTNER, G. KRIEGER, A. SAUER, P. STEVENS, H. D. VOLK & A. WENDEL. 1995. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85: 2482-2489.
9. HEBERT, J. C., M. O'REILLY & R. L. GAMELLI. 1990. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch. Surg. 125: 1075.
10. POLLMÄCHER, T., C. KORTH, J. MULLINGTON, W. SCHREIBER, J. SAUER, H. VEDDER, C. GALANOS & F. HOLSBOER. 1996. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87: 900-905.
11. DOHERTY, G. M., J. C. JENSEN, H. R. ALEXANDER, C. M. BURESH & J. A. NORTON. 1991. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 21: 3423-435.
12. REMICK, D., Y. NEGUSSIE, D. FEKADE & G. GRIFFIN. 1996. Pentoxifylline fails to prevent the Jarisch-Herxheimer reaction or associated cytokine release. J. Infect. Dis. 174: 627-630.
13. DEL MORAL, T., R. GOLDBERG, J. URBON, C. SUGUIHARA, O. MARTINEZ, J. STEIN-STREILEIN, W. J. FEUER & E. BANCALARI. 1996. Effects of treatment with pentoxifylline on the cardiovascular manifestations of group B streptococcal sepsis in the piglet. Pediatr. Res. 40: 469-473.
14. LECHNER, A. J., L. R. ROUBEN, L. H. POTTHOFF, T. L. TREDWAY & G. M. MATUSCHAK. 1993. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. Disseminated candidiasis with fungal septic shock. Circ. Shock 39: 306-315.
15. TIGHE D., R. Moss, J. HYND, S. BOGHOSSIAN, N. AL-SAADY, M. F. HEATH & E. D. BENNETT. 1990. Pretreatment with pentoxifylline improves the hemodynamic and histologic changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model. Crit. Care Med. 18: 184-189.
16. SALYER, J. L., J. F. BOHNSACK, W. A. KNAPE, A. O. SHIGEOKA, E. R. ASHWOOD & H. R. HILL. 1990. Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration. Am. J. Pathol. 136: 831-841.
17. CURRIE, M. S., K. M. RAO, J. PADMANABHAN, A. JONES, J. CRAWFORD & H. J. COHEN. 1990. Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and Superoxide production. J. Leuk. Biol. 47: 244-250.
18. SULLIVAN, G. W., T. N. PATSELAS, J. A. REDICK & G. L. MANDELL. 1984. Enhancement of chemotaxis and protection of mice from infection. Trans. Assoc. Am. Physicans 97: 337-345.
19. DEISHER, TA., I. GARCIA & J. M. HARLAN. 1993. Cytokine-induced adhesion molecule expression on human umbilical vein endothelial cells is not regulated by cyclic adenosine monophosphate accumulation. Life Sci. 53: 365-370.
20. MORANDINI, R., G. GHANEM, A. PORTIER-LEMARIÉ, B. ROBAYE, A. RENAUD & J. M. BOEYNAEMS. 1996. Action of cAMP on expression and release of adhesion molecules in human endothelial cells. Am. J. Physiol. 270: H807-H816.
21. BONE, R. C. 1996. Why sepsis trials fail. J. Am. Med. Assoc. 276: 565-566.
22. GOLDIE, A. S., K. C. H. FEARON, J. A. Ross, G. R. BARCLAY, R. E. JACKSON, I. S. GRANT, G. RAMSAY, A. S. BLYTH & J. C. HOWIE. 1995. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. J. Am. Med. Assoc. 274: 172-177.
23. SULLIVAN, G. W., H. T. CARPER, J. B. HYLTON, W. J. NOVICK, JR. & G. MANDELL. 1990. Lack of correlation between TNF-inhibition and enhanced PMN oxidative activity and adherence: Implications for mechanisms of pentoxifylline action. In Pentoxifylline and Analogues: Effects on Leukocyte Function, pp. 1-8. Karger. Basel.
24. CONDLIFFE, A. M., E. R. CHILVERS, C. HASLETT & I. DRANSFIELD. 1996. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 89: 105-111.
25. RAO, K. M. K., J. PADMANABHAN, H. J. COHEN & M. S. CURRIE. 1990. Effect of pentoxifylline and analogs on actin state and cell surface receptor expression in human leukocytes. In Pentoxifylline and Analogues: Effects on Leukocyte Function, pp. 64-70. Karger. Basel.
26. WANG, J. M., Z. G. CHEN, S. COLELLA, M. A. BONILLA, K. WELTE, C. BORDIGNON & A. MANTOVANI. 1988. Chemotactic activity of recombinant granulocyte-stimulating factor. Blood 72: 1456-1460.
27. TOMHAVE, E. D., R. M. RICHARDSON, J. R. DIDSBURY, L. MENARD, R. SNYDERMAN & H. ALI. 1994. Cross-desensitization of receptors for peptide chemoattractants. J. Immunol. 153: 3267.